- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01768065
Nasal Expiratory Positive Airway Pressure for the Treatment of Pediatric Obstructive Sleep Apnea Syndrome
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Tidlig fase 1
Kontakter og lokationer
Studiesteder
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Children's Hospital of Philadelphia
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Subjects age 5-16 years (note: Due to the size of the devices, it is expected that most children will be at least 8 years old, but a few may be younger. Subjects will be evaluated in clinic to fit for size and habituate to the device)
- OSAS (AHI > 5/hr)
- Subject has had adenotonsillectomy or is not a candidate for adenotonsillectomy
- Subject is non-adherent to CPAP or is seeking an alternative therapy
- Tolerance of NEPAP device during a daytime session
- Parental/guardian permission (informed consent) and if appropriate, child assent.
Exclusion Criteria:
- Severe developmental delay thought to involve a high risk of aspiration
- Family does not understand English well enough to perform the standardized, validated questionnaires.
- Age >16 years since results may be similar to adult studies in these older patients.
- Severe breathing disorder (including respiratory muscle weakness, bullous lung disease, bypassed upper airway, pneumothorax, pneumomediastinum)
- Severe heart disease (including heart failure)
- An acute upper respiratory (including nasal, sinus or middle ear) inflammation or infection or perforation of the ear drum
Subjects that do not meet all of the enrollment criteria will not be enrolled. Any violations of these criteria will be reported in accordance with Institutional Review Board (IRB) Policies and Procedures.
Study members will not recruit females who are known to be pregnant. However, if a subject becomes pregnant during the study, we will continue to use the device. Pregnancy is not an exclusion criterion as positive airway pressure therapy does not harm the pregnant woman or fetus.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Nasal Expiratory Positive Airway Pressure Devices
Nasal Expiratory Positive Airway Pressure Device
|
assigned to Nasal Expiratory Positive Airway Pressure arm
|
Sham-komparator: placebo sham
A sham device
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Apnea hypopnea index
Tidsramme: Approximately one week
|
The apnea hypopnea index during polysomnography will be compared between the active device and the placebo nights
|
Approximately one week
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Adherence using daily logs
Tidsramme: One month
|
Adherence with using devices will be determined by daily logs and collecting used devices
|
One month
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Quality of life
Tidsramme: One Month
|
The Pediatric Quality of Life (PedsQL) score will be compared at baseline and after one month of device usage
|
One Month
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Carole Marcus, Children's Hospital of Philadelphia
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 12-008691
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .